Re: The first report on coronavirus disease 2019 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey: Consideration of recent findings on COVID-19 vaccine adherence in cancer patients
Eur J Cancer
.
2021 Nov:158:251-252.
doi: 10.1016/j.ejca.2021.07.048.
Epub 2021 Sep 25.
Authors
Luigi Cavanna
1
,
Chiara Citterio
2
,
Evelina Cattadori
3
,
Costanza Bosi
2
,
Serena Caprioli
4
Affiliations
1
Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy. Electronic address: l.cavanna@ausl.pc.it.
2
Oncology and Hematology Department, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy.
3
Research and Innovation Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy.
4
Administration Unit, Piacenza General Hospital, Via Taverna 49, Piacenza, 29121, Italy.
PMID:
34649763
PMCID:
PMC8463312
DOI:
10.1016/j.ejca.2021.07.048
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Italy / epidemiology
Neoplasms*
SARS-CoV-2
Vaccination
Vaccination Refusal
Substances
COVID-19 Vaccines